ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,314Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 143

$655K Total Retail Price of All Prescriptions

Rank: 16 out of 143

404 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 9,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 513 389 1 1
SIMVASTATIN 427 339 2 2
WARFARIN SODIUM 397 375 3 15
FUROSEMIDE 365 301 4 6
LEVOTHYROXINE SODIUM 347 290 5 3
ATENOLOL 343 278 6 11
HYDROCHLOROTHIAZIDE 327 244 7 10
METOPROLOL TARTRATE 234 213 8 12
OMEPRAZOLE 217 186 9 5
CARVEDILOL 215 188 10 22
AMLODIPINE BESYLATE 196 191 11 4
GLIMEPIRIDE 173 150 12 27
METOPROLOL SUCCINATE 173 127 12 14
POTASSIUM CHLORIDE 172 143 14 34
FELODIPINE ER 165 151 15 82
TRAMADOL HCL 146 108 16 16
ADVAIR DISKUS 144 102 17 42
HYDRALAZINE HCL 139 131 18 64
POLYETHYLENE GLYCOL 3350 135 127 19 45
MIRTAZAPINE 134 134 20 30
METFORMIN HCL 133 108 21 8
DIVALPROEX SODIUM 130 121 22 80
DONEPEZIL HCL 123 110 23 36
FLUTICASONE PROPIONATE 123 70 23 37
ATORVASTATIN CALCIUM 120 104 25 7
OXYCODONE-ACETAMINOPHEN 119 62 S2 26 56
HYDROCODONE-ACETAMINOPHEN 114 109 S3 27 20
TAMSULOSIN HCL 113 90 28 28
RANITIDINE HCL 111 76 29 41
GABAPENTIN 105 56 30 18
FENTANYL 98 95 S2 31 83
SPIRIVA 98 52 31 38
SERTRALINE HCL 95 69 33 23
QUETIAPINE FUMARATE 92 82 34 53
RISPERIDONE 91 83 35 61
CLOPIDOGREL 79 53 36 33
KLOR-CON M20 76 66 37 69
IPRATROPIUM-ALBUTEROL 75 68 38 103
PRAVASTATIN SODIUM 70 64 39 9
NAMENDA 70 70 39 49
LIDODERM 69 67 41 129
FINASTERIDE 69 56 41 97
ESCITALOPRAM OXALATE 69 52 41 46
LEVETIRACETAM 67 53 44 74
NAPROXEN 65 39 45 81
CIPROFLOXACIN HCL 64 54 46 58
KLOR-CON M10 64 58 46 99
OLANZAPINE 62 59 48 100
PHENYTOIN SODIUM EXTENDED 62 61 48 141
ISOSORBIDE MONONITRATE ER 60 56 50 44
LEXAPRO 60 42 50 141
HUMALOG 59 40 52 127
ALBUTEROL SULFATE 58 47 53 102
HUMULIN 70-30 57 52 54 207
CRESTOR 57 43 54 17
LANTUS 54 36 56 65
CITALOPRAM HBR 54 51 56 25
DIOVAN 54 49 56 26
QUINAPRIL HCL 53 34 59 124
PROMETHAZINE HCL 53 24 R 59 139
CEPHALEXIN 53 50 59 119
AMIODARONE HCL 50 48 62 165
OXYCONTIN 50 0 S2 62 111
ABILIFY 50 38 62 125
TRAZODONE HCL 50 50 62 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 3, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.